Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chih-Teng Yu
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI Resistance in Lung Adenocarcinoma: The Role of RELB
Oncotarget
Oncology
Related publications
P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR-TKI and Lung Adenocarcinoma With CNS Relapse: Interest of Molecular Follow-Up
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer
Oncology Letters
Cancer Research
Oncology
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients With EGFR-Mutant Lung Cancers
Clinical Cancer Research
Cancer Research
Oncology
EGFR Inhibitors in Treatment of Lung Adenocarcinoma
Research in Oncology
P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
